Anixa Biosciences, Inc.
NASDAQ:ANIX
3.62 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Anixa Biosciences, Inc. |
Symbool | ANIX |
Munteenheid | USD |
Prijs | 3.62 |
Beurswaarde | 116,489,786 |
Dividendpercentage | 0% |
52-weken bereik | 2.15 - 5.13 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Amit Kumar Ph.D. |
Website | https://www.anixa.com |
An error occurred while fetching data.
Over Anixa Biosciences, Inc.
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)